QS Investors LLC grew its stake in shares of Danaher Co. (NYSE:DHR) by 3.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,849 shares of the conglomerate’s stock after acquiring an additional 851 shares during the period. QS Investors LLC’s holdings in Danaher were worth $2,678,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of DHR. Zions Bancorporation lifted its position in shares of Danaher by 118.3% during the 3rd quarter. Zions Bancorporation now owns 1,231 shares of the conglomerate’s stock valued at $106,000 after acquiring an additional 667 shares during the period. Patten Group Inc. lifted its position in shares of Danaher by 262.3% during the 3rd quarter. Patten Group Inc. now owns 4,830 shares of the conglomerate’s stock valued at $114,000 after acquiring an additional 3,497 shares during the period. First Personal Financial Services lifted its position in shares of Danaher by 128.9% during the 4th quarter. First Personal Financial Services now owns 1,227 shares of the conglomerate’s stock valued at $114,000 after acquiring an additional 691 shares during the period. Calton & Associates Inc. acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $114,000. Finally, Truewealth LLC acquired a new stake in shares of Danaher during the 4th quarter valued at approximately $121,000. Institutional investors own 77.64% of the company’s stock.
A number of brokerages have recently weighed in on DHR. Credit Suisse Group raised their price objective on shares of Danaher from $106.00 to $108.00 and gave the stock an “outperform” rating in a research note on Tuesday, March 13th. Deutsche Bank dropped their price objective on shares of Danaher from $114.00 to $107.00 and set a “buy” rating for the company in a research note on Thursday, March 1st. Barclays began coverage on shares of Danaher in a research note on Thursday, February 15th. They set an “overweight” rating and a $110.00 price objective for the company. Argus raised their price objective on shares of Danaher from $100.00 to $115.00 and gave the stock a “buy” rating in a research note on Thursday, February 1st. Finally, Royal Bank of Canada reissued a “hold” rating and set a $98.00 price objective on shares of Danaher in a research note on Wednesday, January 31st. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $101.40.
In other Danaher news, insider Rainer Blair sold 51,080 shares of Danaher stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $97.26, for a total value of $4,968,040.80. Following the completion of the sale, the insider now directly owns 50,477 shares of the company’s stock, valued at approximately $4,909,393.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Walter G. Lohr sold 10,578 shares of Danaher stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $97.90, for a total transaction of $1,035,586.20. Following the completion of the sale, the director now directly owns 19,821 shares of the company’s stock, valued at $1,940,475.90. The disclosure for this sale can be found here. Insiders sold a total of 313,260 shares of company stock valued at $31,657,786 over the last ninety days. 12.20% of the stock is owned by corporate insiders.
Shares of Danaher stock opened at $101.93 on Monday. The company has a market cap of $71,103.26, a P/E ratio of 28.88, a price-to-earnings-growth ratio of 2.14 and a beta of 1.03. The company has a quick ratio of 1.05, a current ratio of 1.43 and a debt-to-equity ratio of 0.39. Danaher Co. has a 12 month low of $78.97 and a 12 month high of $104.82.
Danaher (NYSE:DHR) last released its earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The firm had revenue of $5.09 billion during the quarter, compared to analysts’ expectations of $4.97 billion. Danaher had a net margin of 13.60% and a return on equity of 11.36%. Danaher’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the previous year, the company earned $1.05 EPS. equities analysts anticipate that Danaher Co. will post 4.37 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Thursday, March 29th will be paid a $0.16 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.14. This represents a $0.64 annualized dividend and a yield of 0.63%. The ex-dividend date of this dividend is Wednesday, March 28th. Danaher’s payout ratio is presently 15.86%.
COPYRIGHT VIOLATION WARNING: This piece was published by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this piece on another website, it was illegally copied and reposted in violation of international trademark & copyright legislation. The correct version of this piece can be accessed at https://ledgergazette.com/2018/03/19/qs-investors-llc-boosts-stake-in-danaher-co-dhr.html.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.